Tags

Type your tag names separated by a space and hit enter

Why not consider an endothelin receptor antagonist against SARS-CoV-2?
Med Hypotheses. 2020 Aug; 141:109792.MH

Links

PMC Free PDF

Authors+Show Affiliations

Javor S
Dermatology Unit, Galliera Hospital, Genoa, Italy. Electronic address: javor.med@gmail.com.
Salsano A
Division of Cardiac Surgery, Policlinico San Martino, DISC Department, University of Genoa, Italy.

MeSH

Anti-Inflammatory AgentsAntiviral AgentsBetacoronavirusBosentanCOVID-19Cells, CulturedCoronavirus InfectionsCytokinesDrug Evaluation, PreclinicalDrug Therapy, CombinationEndothelin A Receptor AntagonistsHumansModels, BiologicalPandemicsPneumonia, ViralRNA, ViralReceptor, Endothelin ASARS-CoV-2ValsartanVirus DiseasesCOVID-19 Drug Treatment

Pub Type(s)

Letter

Language

eng

PubMed ID

32361169

Citation

Javor, S, and A Salsano. "Why Not Consider an Endothelin Receptor Antagonist Against SARS-CoV-2?" Medical Hypotheses, vol. 141, 2020, p. 109792.
Javor S, Salsano A. Why not consider an endothelin receptor antagonist against SARS-CoV-2? Med Hypotheses. 2020;141:109792.
Javor, S., & Salsano, A. (2020). Why not consider an endothelin receptor antagonist against SARS-CoV-2? Medical Hypotheses, 141, 109792. https://doi.org/10.1016/j.mehy.2020.109792
Javor S, Salsano A. Why Not Consider an Endothelin Receptor Antagonist Against SARS-CoV-2. Med Hypotheses. 2020;141:109792. PubMed PMID: 32361169.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Why not consider an endothelin receptor antagonist against SARS-CoV-2? AU - Javor,S, AU - Salsano,A, Y1 - 2020/04/25/ PY - 2020/3/29/received PY - 2020/4/24/accepted PY - 2020/5/4/pubmed PY - 2020/7/4/medline PY - 2020/5/4/entrez SP - 109792 EP - 109792 JF - Medical hypotheses JO - Med Hypotheses VL - 141 SN - 1532-2777 UR - https://www.unboundmedicine.com/medline/citation/32361169/Why_not_consider_an_endothelin_receptor_antagonist_against_SARS_CoV_2 DB - PRIME DP - Unbound Medicine ER -